Topical peptides and proteins for aging skin

Textbook of Aging Skin

Volumn , Issue , 2010, Pages 1089-1117

  Gorouhi, Farzam ^a   Maibach, Howard I ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892002590     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-89656-2_101     Document Type: Chapter

References (139)

1. Kosmadaki MG, Gilchrest BA. The demographics of aging in the United States: Implications for dermatology. Arch Dermatol. 2002;138:1427-1428.
2. Ranade VV. Drug delivery systems. 6. Transdermal drug delivery. J Clin Pharmacol. 1991;31:401-418.
3. Buri P, Puisieux F, Doelker E, et al. Formes pharmaceutiques nouvelles. Technique et Documentation, Paris, 1985.
4. Vecchia BE, Bunge AL. Evaluating the transdermal permeability of chemicals. In: Guy RH, Hadgraft J (eds) Transdermal Drug Delivery (Electronic Resource). New York: Dekker, 2003.
5. Guy RH. Current status and future prospects of transdermal drug delivery. Pharm Res. 1996;13:1765-1769.
6. Roberts MS, Cross SE, Pellett MA. Skin transport. In: Walters AW (ed) Dermatological and Transdermal Formulations. New York: Dekker, 2002, p. 121.
7. Cullander C, Guy RH. Routes of delivery: Case studies (6). Trasdermal delivery of peptides and proteins. Adv Drug Deliv Rev. 1992; 8:291-329.
8. Nakamura RM, Einck L, Velmonte MA, Kawajiri K, Ang CF, Delasllagas CE, et al. Detection of active tuberculosis by an MPB-64 transdermal patch: A field study. Scand J Infect Dis. 2001; 33:405-407.
9. Pai M, Kalantari S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn. 2006;6:423-432.
10. Billich A, Aschauer H, Aszodi A, Stuetz A. Percutaneous absorption of drugs used in atopic eczema: Pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm. 2004;269:29-35.
11. Weiss M, Fresneau M, Monius T, Stutz A, Billich A. Binding of pimecrolimus and tacrolimus to skin and plasma proteins: Implications for systemic exposure after topical application. Drug Metab Dispos. 2008;36:1812-1818.
12. Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: A phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008;371: 2019-2025.
13. Billich A, Vyplel H, Grassberger M, Schmook FP, Steck A, Stuetz A. Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight. Bioorg Med Chem. 2005;13: 3157-3167.
14. Smith EW, Maibach HI. Percutaneous Penetration Enhancers. New York: Taylor & Francis, 2006.
15. Pillai O, Panchagnula R. Transdermal delivery of insulin from poloxamer gel: Ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J Control Release. 2003;89: 127-140.
16. Silva R, Little C, Ferreira H, Cavaco-Paulo A. Incorporation of peptides in phospholipid aggregates using ultrasound. Ultrason Sonochem. 2008;15:1026-1032.
17. Goebel A, Neubert RH. Dermal peptide delivery using colloidal carrier systems. Skin Pharmacol Physiol. 2008;21:3-9.
18. Chen Y, Shen Y, Guo X, Zhang C, Yang W, Ma M, et al. Transdermal protein delivery by a coadministered peptide identified via phage display. Nat Biotechnol. 2006;24:455-460.
19. Foldvari M, Attah-Poku S, Hu J, Li Q, Hughes H, Babiuk LA, et al. Palmitoyl derivatives of interferon alpha: Potential for cutaneous delivery. J Pharm Sci. 1998;87:1203-1208.
20. Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27: 155-160.
21. Abdulghani AA, Sherr A, Shirin S, Solodkina G, Morales Tapia E, Wolf B, et al. Effects of topical creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin. Dis Manage Clin Outcomes 1998;1:136-141.
22. Osborne R, Robinson LR, Mullins L, Raleigh P. Use of a facial moisturizer containing palmitoyl pentapeptide improves the appearance of aging skin. J Am Acad Dermatol. 2005;52:96.
23. Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernandez-Ballester G, Ponsati B, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002;24:303-310.
24. Samuel M, Brooke RC, Hollis S, Griffiths CE. Interventions for photodamaged skin. Cochrane Database Syst Rev. 2005;CD001782.
25. Mazurowska L, Mojski M. Biological activities of selected peptides: Skin penetration ability of copper complexes with peptides. J Cosmet Sci. 2008;59:59-69.
26. Ruland A, Kreuter J, Rytting JH. Transdermal delivery of the tetrapeptide hisetal (melanotropin (6-9)): II. Effect of various penetration enhancers. In vitro study across human skin. Int J Pharm. 1994;103:77-80.
27. Ruland A, Kreuter J, Rytting JH. Transdermal delivery of the tetrapeptide hisetal (melanotropin (6-9)). I. Effect of various penetration enhancers: In vitro study across hairless mouse skin. Int J Pharm. 1994;101:57-61.
28. Mazurowska L, Nowak-Buciak K, Mojski M. ESI-MS method for in vitro investigation of skin penetration by copper-amino acid complexes: From an emulsion through a model membrane. Anal Bioanal Chem. 2007;388:1157-1163.
29. Ruland A, Kreuter J. Transdermal permeability and skin accumulation of amino acids. Int J Pharm. 1991;72:149-155.
30. Braun E, Wagner A, Furnschlief E, Katinger H, Vorauer-Uhl K. Experimental design for in vitro skin penetration study of liposomal superoxide dismutase. J Pharm Biomed Anal. 2006;40:1187-1197.
31. Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243:85-87.
32. Maquart FX, Siméon A, Pasco S, Monboisse JC. Regulation of cell activity by the extracellular matrix: The concept of matrikines. J Soc Biol. 1999;193:423-428.
33. Simeon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: Modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu (2 +). J Invest Dermatol. 2000;115:962-968.
34. Simeon A, Emonard H, Hornebeck W, Maquart FX. The tripeptidecopper complex glycyl-L-histidyl-L-lysine-Cu2 + stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67:2257-2265.
35. Buffoni F, Pino R, Dal Pozzo A. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Arch Int Pharmacodyn Ther. 1995;330:345-360.
36. Wegrowski Y, Maquart FX, Borel JP. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-Lhistidyl-L-lysine-Cu2 +. Life Sci. 1992;51:1049-1056.
37. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2 +. FEBS Lett. 1988;238:343-346.
38. Lintner K. Promoting production in the extracellular matrix without compromising barrier. Cutis. 2002;70:13-16, discussion 21-23.
39. Croda, Croda USA-News and News Releases, Croda.
40. Pentapharm, Syn1-Coll, Basel.
41. Centerchem, Decorinyl™, Basel.
42. Puig A, Anton JMG, Mangues M. A new decorin-like tetrapeptide for optimal organization of collagen fibres. Int J Cosmet Sci. 2008;30:97-104.
43. Croda, Biopeptide EL™, Edison.
44. A.p.c. products, Peptamide™6, A firming hexapeptide. South Plainfield.
45. Osborne R, Mullins L, Jarrold B, Lintner K. In vitro skin structure benefits with a new antiaging peptide, Pal-KT. J Am Acad Dermatol. 2008;58:ab25 (Abstract).
46. Tajima S, Wachi H, Uemura Y, Okamoto K. Modulation by elastin peptide VGVAPG of cell proliferation and elastin expression in human skin fibroblasts. Arch Dermatol Res. 1997;289: 489-492.
47. Wachi H, Seyama Y, Yamashita S, Suganami H, Uemura Y, Okamoto K, et al. Stimulation of cell proliferation and autoregulation of elastin expression by elastin peptide VPGVG in cultured chick vascular smooth muscle cells. FEBS Lett. 1995;368:215-219.
48. Fujimoto N, Tajima S, Ishibashi A. Elastin peptides induce migration and terminal differentiation of cultured keratinocytes via 67 kDa elastin receptor in vitro: 67 kDa elastin receptor is expressed in the keratinocytes eliminating elastic materials in elastosis perforans serpiginosa. J Invest Dermatol. 2000;115:633-639.
49. Chang CH, Kawa Y, Tsai RK, Shieh JH, Lee JW, et al. Melanocyte precursors express elastin binding protein and elastin-derived peptide (VGVAPG) stimulates their melanogenesis and dendrite formation. J Dermatol Sci. 2008;51:158-80.
50. Gruber JV, Bouldin L, Lou K. Can a topical scalp treatment reduce hair bulb extraction? J Cosmet Sci. 2007;58:369-374.
51. Ennamany R, Saboureau D, Mekideche N, Creppy EE. SECMA 1, a mitogenic hexapeptide from Ulva algae modulates the production of proteoglycans and glycosaminoglycans in human foreskin fibroblast. Hum Exp Toxicol. 1998;17:18-22.
52. Dumas M, Sadick NS, Noblesse E, Juan M, Lachmann-Weber N, Boury-Jamot M, et al. Hydrating skin by stimulating biosynthesis of aquaporins. J Drugs Dermatol. 2007;6:s20-24.
53. Pauly G, Contet-Audonneau J, Moussou P, Danoux L, Bardey V, Freis O, et al. Small proteoglycans in the skin: New targets in the fight against aging. IFSCC. 2008;11:21-29.
54. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, et al. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA. 1993;90:3889-3893.
55. Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999;140:4089-4094.
56. Cohen IK, Crossland MC, Garrett A, Diegelmann RF. Topical application of epidermal growth factor onto partial-thickness wounds in human volunteers does not enhance reepithelialization. Plast Reconstr Surg 1995;96:251-254.
57. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger Iii LJ, et al. Enhancement of wound healing by topical treatment with epidermal growth factor. New Engl J Med. 1989;321:76-79.
58. Miller CO, Skong F, Von Saltza MH, Strong FM. Kinetin, a cell division factor from deoxyribonucleic acid. J Am Chem Soc. 1955;77:1392.
59. Miller CO, Skong F, Okumura FS, Von Saltza MH, Strong FM. Isolation, structure, and synthesis of kinetin, a substance promoting cell division. J Am Chem Soc. 1956;78:1375-1380.
60. Berge U, Kristensen P, Rattan SI. Kinetin-induced differentiation of normal human keratinocytes undergoing aging in vitro. Ann N Y Acad Sci. 2006;1067:332-336.
61. Sharma SP, Kaur P, Rattan SIS. Plant growth hormone kinetin delays ageing, prolongs the lifespan and slows down development of the fruitfly Zaprionus paravittiger. Biochem Biophys Res Commun. 1995;216:1067-1071.
62. Rattan SIS, Clark BFC. Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun. 1994;201:665-672.
63. Barciszewski J, Rattan SI, Siboska G, Clark BFC Kinetin-45 years on. Plant Sci. 1999;148:37-45.
64. Olsen A, Siboska GE, Clark BFC, Rattan SIS. N6-Furfuryladenine, kinetin, protects against fenton reaction-mediated oxidative damage to DNA. Biochem Biophys Res Commun. 1999;265:499-502.
65. Verbeke P, Siboska GE, Clark BFC, Rattan SIS. Kinetin inhibits protein oxidation and glycoxidation in vitro. Biochem Biophys Res Commun. 2000;276:1265-1270.
66. Hipkiss AR. On the "struggle between chemistry and biology during aging"-Implications for DNA repair apoptosis and proteolysis, and a novel route of intervention. Biogerontology 2001;2: 173-178.
67. Kimura T, Doi K. Depigmentation and rejuvenation effects of kinetin on the aged skin of hairless descendants ofMexican hairless dogs. Rejuvenation Res. 2004;7:32-39.
68. Katz BE, Bruck MC. Efficacy and tolerability of kinetin 0.1% cream for improving the signs of photoaging in facial and neck skin. Cosmet Dermatol. 2006;19:736-741.
69. McCullough JL, Weinstein GD. Clinical study of safety and efficacy of using topical kinetin 0.1% (Kinerase(registered trademark)) to treat photodamaged skin. Cosmet Dermatol. 2002;15:29-32.
70. Levy SB. Kinetin. In: Elsner P, Maibach HI (eds) Cosmeceuticals and Active Cosmetics. New York: Marcel Dekker, 2005: 407-419.
71. Dickens MS, Levy SB, Helman MD, Nucci JE. Kinetin containing lotion compared with retinol containing lotion; Comparable improvements in the signs of photoaging. American Academy of Dermatology 60th Annual Meeting, New Orleans, LA, USA, 2002, p. 28.
72. Chiu PC, Chan CC, Lin HM, Chiu HC. The clinical anti-aging effects of topical kinetin and niacinamide in Asians: A randomized, double-blind, placebo-controlled, split-face comparative trial. J Cosmet Dermatol. 2007;6:243-249.
73. McCullough JL, Garcia RL, Reece B. A clinical study of topical Pyratine 6 for improving the appearance of photodamaged skin. J Drugs Dermatol. 2008;7:131-135.
74. Arendt J. Melatonin. Clin Endocrinol (Oxf) 1988;29:205-229.
75. Fischer TW, Elsner P. The antioxidative potential of melatonin in the skin. Curr Probl Dermatol. 2001;29:165-174.
76. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59:1609-1623.
77. Fischer T, Wigger-Alberti W, Elsner P. Melatonin in dermatology: Experimental and clinical aspects. Hautarzt. 1999;50:5-11.
78. Karbownik M, Reiter RJ. Melatonin protects against oxidative stress caused by (delta)-aminolevulinic acid: Implications for cancer reduction. Cancer Invest. 2002;20:276-286.
79. Chun Kim B, Sung Shon B, Wook Ryoo Y, Pyo Kim S, Suk Lee K. Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts. J Dermatol Sci. 2001;26:194-200.
80. YoungWook R, Seong Il S, Kyo Cheol M, Byung Chun K, Kyu Suk L. The effects of the melatonin on ultraviolet-B irradiated cultured dermal fibroblasts. J Dermatol Sci. 2001;27:162-169.
81. Fischer TW, Scholz G, Knoll B, Hipler UC, Eisner P. Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J Pineal Res. 2001;31:39-45.
82. Fischer TW, Scholz G, Knoll B, Hipler UC, Elsner P. Melatonin suppresses reactive oxygen species in UV-irradiated leukocytes more than vitamin C and trolox. Skin Pharmacol Appl Skin Physiol. 2002;15:367-373.
83. Fischer T, Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin. Influence of the application time point. Biol Signals Recept 1999;8:132-135.
84. Ghersetich I, Comacchi C, Lotti T. Immunohistochemical and ultrastructural investigation of multiple common warts before and after therapy with alpha-interferon. Giornale Italiano di Dermatologia e Venereologia 1992;127:207-210.
85. Ghersetich I, Lotti T. Alpha-interferon cream restores decreased levels of Langerhans/indeterminate (CD1a +) cells in aged and PUVA-treated skin. Skin Pharmacol. 1994;7:118-120.
86. Frank S, Madlener M, Werner S. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem. 1996;271:10188-10193.
87. Li Y, Fan J, Chen M, Li W, Woodley DT. Transforming growth factor-alpha: A major human serum factor that promotes human keratinocyte migration. J Invest Dermatol. 2006;126:2096-2105.
88. Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther. 2003;98:257-265.
89. Rao J, Ehrlich M, Goldman MP Facial skin rejuvenation with a novel topical compound containing transforming growth factor (beta)1 and vitamin C. Cosmet Dermatol. 2004;17:705-710.
90. Ehrlich M, Rao J, Pabby A, Goldman MP. Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and l-ascorbic acid. Dermatol Surg. 2006;32: 618-625.
91. Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: A pilot study. J Cosmet Laser Ther. 2003;5:25-34.
92. Gold MH, Goldman MP, Biron J. Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation. J Drugs Dermatol. 2007;6:197-201.
93. Lupo ML, Cohen JL, Rendon MI. Novel eye cream containing a mixture of human growth factors and cytokines for periorbital skin rejuvenation. J Drugs Dermatol. 2007;6:725-729.
94. Gold MH, Goldman MP, Biron J. Human growth factor and cytokine skin cream for facial skin rejuvenation as assessed by 3D in vivo optical skin imaging. J Drugs Dermatol. 2007;6:1018-1023.
95. Watson RE, Long SP, Bowden JJ, Bastrilles JY, Barton SP, Griffiths CE. Repair of photoaged dermal matrix by topical application of a cosmetic "antiageing" product. Br J Dermatol. 2008;158:472-477.
96. Dal Farra C, Bauza E, Domloge N. Heat shock proteins for cosmeceuticals. In: Elsner P, Maibach HI (eds) Cosmeceuticals and Active Cosmetics. New York: Marcel Dekker, 2005, pp. 523-536.
97. Botto J, Cucumel K, Dal Farra C, Domloge N. Treatment of human cells with Hsp-70-rich yeast extract enhances cell thermotolerance and resistance to stress. J Invest Dermatol. 2001;117:452.
98. Cucumel K, Botto J, Bauza E, Dal Farra C, Roetto R, Domloge N. Artemia extract induces Hsp70 in human cells and enhances cell protection from stress. J Invest Dermatol. 2001;117:454.
99. Domloge N, Bauza E, Cucumel K, Peyronel D, Dal Farra C. Artemia extract toward more extensive sun protection. Cosmet Toiletries. 2002;2002:69-78.
100. Bauza E, Dal Farra C, Domloge N. Hsp70 induction by Artemia extract exhibits anti-inflammatory effect and down-regulates IL-1 and IL-8 synthesis in human hacat cells. J Invest Dermatol. 2001;117:415.
101. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stressinduced apoptosis. Mol Cell Biol. 1997;17:5317-5327.
102. Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI, et al. Hsp70 prevents activation of stress kinases: A novel pathway of cellular thermotolerance. J Biol Chem. 1997;272:18033-18037.
103. Gutsmann-Conrad A, Heydari AR, You S, Richardson A. The expression of heat shock protein 70 decreases with cellular senescence in vitro and in cells derived from young and old human subjects. Exp Cell Res. 1998;241:404-413.
104. Wu B, Gu MJ, Heydari AR, Richardson A. The effect of age on the synthesis of two heat shock proteins in the HSP70 family. J Gerontol. 1993;48:B50-B56.
105. Blake MJ, Fargnoli J, Gershon D, Holbrook NJ. Concomitant decline in heat-induced hyperthermia and HSP70 mrna expression in aged rats. Am J Physiol Regul Integr Comp Physiol. 1991;260: R663-R667.
106. Pardue S, Groshan K, Raese JD, Morrison-Bogorad M. Hsp70 mrna induction is reduced in neurons of aged rat hippocampus after thermal stress. Neurobiol Aging. 1992;13:661-672.
107. Fargnoli J, Kunisada T, Fornace Jr AJ, Schneider EL, Holbrook NJ. Decreased expression of heat shock protein 70 mrna and protein after heat treatment in cells of aged rats. Proc Natl Acad Sci USA. 1990;87:846-850.
108. Muramatsu T, Hataoko M, Tada H, Shirai T, Ohnishi T. Age-related decrease in the inductability of heat shock protein 72 in normal human skin. Br J Dermatol. 1996;134:1035-1038.
109. Cucumel K, Dal Farra C, Domloge N. Artemia extract " compensates" for age-related decrease of Hsp70 in skin. J Invest Dermatol. 2002;119:257.
110. Cauchard JH, Berton A, Godeau G, Hornebeck W, Bellon G. Activation of latent transforming growth factor beta 1 and inhibition of matrix metalloprotease activity by a thrombospondin-like tripeptide linked to elaidic acid. Biochem Pharmacol. 2004;67: 2013-2022.
111. Choi SH, Kim SY, An JJ, Lee SH, Kim DW, Ryu HJ, et al. Human PEP-1-ribosomal protein S3 protects against UV-induced skin cell death. FEBS Lett. 2006;580:6755-6762.
112. Barba C, Mendez S, Roddick-Lanzilotta A, Kelly R, Parra JL, Coderch L. Wool peptide derivatives for hand care. J Cosmet Sci. 2007;58:99-107.
113. Barba C, Mendez S, Roddick-Lanzilotta A, Kelly R, Parra JL, Coderch L. Cosmetic effectiveness of topically applied hydrolysed keratin peptides and lipids derived from wool. Skin Res Technol. 2008;14:243-248.
114. dal Farra C, Oberto G, Berghi A, Domloge N. An anti-aging effect on the lips and skin observed in in vivo studies on a new fibronectin-like peptide. J Am Acad Dermatol. 2007;56:AB88.
115. Centerchem, Glycine soja (soybean) protein, Barcelona, Spain.
116. Sudel KM, Venzke K, Mielke H, Breitenbach U, Mundt C, Jaspers S, et al. Novel aspects of intrinsic and extrinsic aging of human skin: Beneficial effects of soy extract. Photochem Photobiol. 2005;81:581-587.
117. Andre-Frei V, Perrier E, Augustin C, Damour O, Bordat P, Schumann K, et al. A comparison of biological activities of a new soya biopeptide studied in an in vitro skin equivalent model and human volunteers. Int J Cosmet Sci. 1999;21:299-311.
118. Sim GS, Lee DH, Kim JH, An SK, Choe TB, Kwon TJ, et al. Black rice (Oryza sativa L. var. japonica) hydrolyzed peptides induce expression of hyaluronan synthase 2 gene in hacat keratinocytes. J Microbiol Biotechnol 2007;17:271-279.
119. Centerchem, Eyeseryl1, Barcelona, Spain.
120. Padamwar MN, Pawar AP, Daithankar AV, Mahadik KR. Silk sericin as a moisturizer: An in vivo study. J Cosmet Dermatol. 2005;4:250-257.
121. Daithankar AV, Padamwar MN, Pisal SS, Paradkar AR, Mahadik KR. Moisturizing efficiency of silk protein hydrolysate: Silk fibroin. Indian J Biotechnol. 2005;4:115-121.
122. Zhaorigetu S, Yanaka N, Sasaki M, Watanabe H, Kato N. Inhibitory effects of silk protein, sericin on UVB-induced acute damage and tumor promotion by reducing oxidative stress in the skin of hairless mouse. J Photochem Photobiol B: Biol. 2003;71:11-17.
123. Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW, Johnson E, et al. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A: Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem. 2003;278:1363-1371.
124. Centerchem, Argireline1, Barcelona.
125. Gutierrez LM, Viniegra S, Rueda J, Ferrer-Montiel AV, Canaves JM, Montal M. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J Biol Chem. 1997;272:2634-2639.
126. Gutierrez LM, Canaves JM, Ferrer-Montiel AV, Reig JA, Montal M, Viniegra S. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca2+-dependent exocytosis in chromaffin cells. FEBS Lett. 1995;372:39-43.
127. Centerchem, Leuphasyl1, Barcelona.
128. Lipotec, SNAP-8, Barcelona.
129. Centerchem, Vialox1, Basel.
130. Snyder EL, Dowdy SF. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opin Drug Deliv. 2005;2:43-51.
131. Hou YW, Chan MH, Hsu HR, Liu BR, Chen CP, Chen HH, et al. Transdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptides. Exp Dermatol. 2007;16:999-1006.
132. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol. 2001;19:1173-1176.
133. Appa Y, Stephens T, Barkovic S, Finkey MB. A clinical evaluation of a copper-peptide-containing liquid foundation and cream concealer designed for improving skin condition. American Academy of Dermatology 60th Annual Meeting, New Orleans, 2002, p. 28.
134. Leyden JJ, Stevens T, Finkey MB, Barkovic S. Skin care benefits of copper-peptide containing facial cream. American Academy of Dermatology 60th Annual Meeting, New Orleans, 2002.
135. Finkey MB, Appa Y, Bhandarkar S. Copper peptide and skin. In: Elsner P, Maibach HI (eds) Cosmeceuticals and Active Cosmetics. New York: Marcel Dekker, 2005, pp. 549-564.
136. Leyden JJ, Stevens T, Finkey MB, Barkovic S. Skin care benefits of copper peptide containing eye creams. American Academy of Dermatology 60th Annual Meeting, New Orleans, 2002.
137. Hussain M, Goldberg DJ. Topical manganese peptide in the treatment of photodamaged skin. J Cosmet Laser Ther. 2007;9:232-236.
138. Naderi-Hachtroudi L, Peters T, Brenneisen P, Meewes C, Hommel C, Razi-Wolf Z, et al. Induction of manganese superoxide dismutase in human dermal fibroblasts: A UV-B-mediated paracrine mechanism with the release of epidermal interleukin 1(alpha), interleukin 1(beta), and tumor necrosis factor (alpha). Arch Dermatol. 2002;138:1473-1479.
139. Parat MO, Richard MJ, Leccia MT, Amblard P, Favier A, Beani JC. Does manganese protect cultured human skin fibroblasts against oxidative injury by UVA, dithranol and hydrogen peroxidé. Free Radic Res. 1995;23:339-351.